Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631 1633 1638 1651 1654 1656 1657
This examiner grants 74% of resolved cases
Robert M Kelly is an examiner in Tech Center 1600 and Art Unit 1631. He has 941 resolved cases. The allowance rate pct is 74.1. This 74.1 allowance rate pct provides a measure of the outcomes for applications on his docket. The 941 resolved cases serve as a basis for evaluating prosecution in Art Unit 1631.
The interview lift pct is 24.6. This 24.6 interview lift pct indicates the correlation between conducting an interview and the probability of an allowance. Practitioners can use the 24.6 figure when deciding whether to engage in verbal advocacy with the examiner. This metric is a component of the data for Tech Center 1600.
The median days to allowance is 1057. This 1057 median days to allowance represents the time required for an application to reach a grant. The 1057 figure is a timeline for the prosecution process from filing to resolution. These metrics provide a view of the examiner's history across the 941 resolved cases.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18342642 | METHODS OF TREATING LYSOSOMAL DISORDERS | Non-Final OA | The Regents of the University of California |
| 18587729 | METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18818917 | MOTOR UNIT CHIP, MANUFACTURING METHOD THEREOF AND METHOD OF DETECTING PATHOLOGICAL EVENT USING THE SAME | Non-Final OA | REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 18511568 | DYSTROPHIN CONSTRUCTS CONTAINING R11-R12 | Non-Final OA | THE CURATORS OF THE UNIVERSITY OF MISSOURI |
| 18703201 | METHODS OF USE AND ADMINISTRATION OF ENCAPSULATED CELLS | Non-Final OA | William Marsh Rice University |
| 18327110 | ENGINEERED CELLS AND METHODS OF USE | Non-Final OA | THE SCRIPPS RESEARCH INSTITUTE |
| 18039391 | ENHANCED NANOPARTICLE DELIVERY SYSTEMS | Non-Final OA | Children's Hospital Medical Center |
| 17829087 | RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES | Non-Final OA | Iovance Biotherapeutics Inc. |
| 18860428 | BIOMATERIALS FOR IMPROVING BRAIN HEALING AFTER STROKE AND METHODS OF USING SAME | Non-Final OA | Duke University |
| 18545176 | Combination Treatment | Non-Final OA | Duke University |
| 18942735 | COMMENSAL FUNGUS AND USES THEREOF | Non-Final OA | YEDA RESEARCH AND DEVELOPMENT CO. LTD. |
| 17909360 | MINIATURE GUIDANCE AND NAVIGATION CONTROL (miniGNC) ANTIBODY-LIKE PROTEINS AND METHODS OF MAKING AND USING THEREOF | Non-Final OA | BAILI-BIO (CHENGDU) PHARMACEUTICAL CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy